KRYS
Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients With Advanced Non-Small Cell Lung Cancer
时间：2024-12-18 21:00:02 市场： 美股
Krystal Biotech Q3 Operating Expenses USD 61.408 Million
时间：2024-11-04 21:00:00 市场： 综合